Theranostics 2021; 11(15):7488-7490. doi:10.7150/thno.61480

Editorial

Mycobiota dysbiosis and gastric tumorigenesis

Nicolas Papon1✉, Tobias M. Hohl2,3,4, Bing Zhai2

1. Univ Angers, Univ Brest, GEIHP, SFR ICAT, F-49000 Angers, France.
2. Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3. Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4. Weill Cornell Medical College, New York, NY, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Papon N, Hohl TM, Zhai B. Mycobiota dysbiosis and gastric tumorigenesis. Theranostics 2021; 11(15):7488-7490. doi:10.7150/thno.61480. Available from https://www.thno.org/v11p7488.htm

File import instruction

Abstract

The gastrointestinal tract contains a vast and diverse microbial reservoir composed of bacteria, fungi, and viruses that contribute positively to human health. There is growing evidence that perturbation of the normal microbiota can promote a variety of human disease states that include tumorigenesis. Whether the fungal component of the gut microbiota (i.e., the mycobiota) can influence tumor development has not been investigated in detail. In the recent issue of the Theranostics, Zhong et al (2021) shed light on an association between mycobiota dysbiosis and gastric cancer. These findings implicate the mycobiota in gastric carcinogenesis and set the stage for future mechanistic studies to explore whether fungal dysbiosis is a cause or consequence of gastric carcinogenesis, with important implications for preventative strategies.

Keywords: Fungi, mycobiota, Candida, cancer, dysbiosis